By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: When a Health Care Business Model Disruption is Self-Destructive
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Innovations > When a Health Care Business Model Disruption is Self-Destructive
DiagnosticsMedical InnovationsMobile HealthPolicy & LawRemote DiagnosticsWellness

When a Health Care Business Model Disruption is Self-Destructive

David Davidovic
David Davidovic
Share
5 Min Read
SHARE

Some time ago, I wrote an article here on the Uberization of Healthcare and how silly that expression is. In essence, I tried to tamper the enthusiasm behind so many healthcare start-ups wanting to disrupt the whole system but having weak premises with which to do so.

Three companies have recently gained notoriety in the healthcare space. Each openly expressing their desire and plans to disrupt everything based on completely new business models – at least that’s what they said.

Valeant:

Some time ago, I wrote an article here on the Uberization of Healthcare and how silly that expression is. In essence, I tried to tamper the enthusiasm behind so many healthcare start-ups wanting to disrupt the whole system but having weak premises with which to do so.

More Read

Image
Using Wireless Networks to Detect Falls In the Elderly
5 CDC Social Media Activities That Influenced Online Conversations About Ebola
HIPAA? Now HIMTA: The New mHealth Bill
Differentiating Between Myths And The Truth About Nootropics
Calorie Myths

Three companies have recently gained notoriety in the healthcare space. Each openly expressing their desire and plans to disrupt everything based on completely new business models – at least that’s what they said.

Valeant:

To be fair, Valeant is a hugely successful pharmaceutical company that seemingly came out of nowhere. They grew very quickly through a long and rapid series of acquisitions. The novelty in their model is that they don’t believe in or need to do any research, which is costly but considered a critical capability in the biopharma sector.

This model works well as long as you keep growing by buying other companies and products, by consolidating operations and cutting costs, by raising prices much faster than inflation and, as they have been accused of doing, by manipulating market channels to their advantage.

The problem is that this is not sustainable in the long run. As we are seeing now and has been reported eslewhere, Valeant is facing huge headwinds as intricacies of their model and possible questionable practices, including pricing, come to light. In addition, at some point you do run out of companies and products to buy – at least at a reasonable price – and without any research, the house of cards starts to fall.

No, they have not invented a new pharma business model.  The model still requires product innovation, volume growth, transparency and respect for regulations.

Theranos:

This little company, started and run by a very smart and ambitious Stanford drop-out visionary with incredible political connections and no healthcare experience, is making a lot of waves. They promised a new business model for diagnostics based on a new proprietary and secret technology that allows many lab tests to be performed with as little as one drop of blood. 

Their model was to disupt the whole diagnostics market. Their approach included maintaining secrecy over their science and methods. Their strategy included not having a single senior scientific member on their board.

Well, sooner or later you do have to face external scrutiny.  The FDA and others, including their retail partners, have started asking questions, and the answers continue to be, “you’ll see, we’ll be releasing all that soon.” In reality, most of the tests that they have been running (all but one) have been done using the same old technolgies and methods.

No, they have not invented a new diagnostics business model. The model still requires science, peer review, and regulatory scrutiny.

Turing

This start-up has become the face of greed, run by an ambitious former hedgefund manager with no experience in the industry or in anything resembling a business with a heart. His business model: buy old products sold for little money and turn around and sell them for a fortune. His model in action: taking an $18 pill drug and overnight change the price to $750.

Not sure if he expected to be able to do this under the radar and not be noticed, but he’s gotten a lot of attention, including from the U.S. Senate. In the process, he has attracted a lot of unwanted attention to the industry, undoing years of value-driven actions and communication efforts. 

No, Turing did not invent a new pharmaceutical business model. The model still requires a justification for prices and price increases as well as sensitivity for customers and patient.

These are three examples of industry disrupter-wannabes who, by ignoring fundamentals, have entered a path of self-destruction.

 

TAGGED:Business ModelethicspharmaceuticalTheranosTuringValeant
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

Image
DiagnosticsMedical DevicesMobile HealthTechnology

mHealth: Prevention is Better Than Cure

February 9, 2013
study for the ACE exam to be a personal trainer
Medical EducationPolicy & Law

4 Tips for Aspiring Personal Trainers to Study for the ACE Exam

April 26, 2022

Cost of Injection Jumps from $15 to $1,500

March 28, 2011
Health careTechnology

Here’s How To Choose Glasses You’ll Love To Wear

March 9, 2019
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?